The size of the Immunoassay Market in the Asia Pacific was worth USD 3.97 Billion in 2020 and is estimated to reach 6.42 Billion by the end of 2025, with a CAGR of 10.12%.
The Asia-pacific market is expected to show the highest growth over the forecast period due to the increasing development of new biologics, drugs, and vaccines.
Immunoassays are biochemical tests used to identify/quantify an analyte in a blood sample using a reaction. Immunoassays are highly specific and sensitive. Their high specificity/sensitivity results from the use of antibodies and purified analytes as reagents. An antibody is a protein produced by immune cells in response to stimulation by an analyte. Immunoassays measure the formation of antibody-antigen complexes and identify them through an indicator reaction. High sensitivity is attained by using an indicator system that results in the intensification of the measured product.
The key drivers of the Asia-Pacific immunoassays market are the rising prevalence of infectious diseases, increasing aging population, advancements in novel assays in various diseases such as Cardiology and oncology, growing applications in diagnosing drug monitoring tests, infectious diseases and identification of cancer biomarkers, increasing need of reagents, sensitive assays and analytical techniques, availability of a wide range of reagents, the introduction of novel biomarkers, growing government and corporate investment in the pharmaceutical and biotechnology segment in emerging markets.
Lack of reimbursement policies, adoption of immunoassays in emerging markets, stringent regulations for storage are hampering the growth of the market.
This research report on the Asia-Pacific Immunoassay Market has been segmented & sub-segmented the market into the following categories:
By Technology:
By Application:
By End User:
By Country:
Key market participants dominating the Asia-Pacific immunoassay market analyzed in this report are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Enzyme Immunoassay
5.1.3 Fluorescent Immunoassays
5.1.4 Cheniluminescence Immunoassays
5.1.5 Nephelometric Immunoassays
5.1.6 Radio Immunoassays
5.1.7 Counting Immunoassays
5.1.8 Counting Immunoassays
5.1.9 Others
5.1.10 Y-o-Y Growth Analysis, By Technology
5.1.11 Market Attractiveness Analysis, By Technology
5.1.12 Market Share Analysis, By Technology
5.2 Application
5.2.1 Introduction
5.2.2 Oncology
5.2.3 Cancer
5.2.4 Hematology
5.2.5 Cardiology
5.2.6 Thyroid
5.2.7 Infectious disease
5.2.8 Allergies
5.2.9 Others
5.2.10 Y-o-Y Growth Analysis, By Application
5.2.11 Market Attractiveness Analysis, By Application
5.2.12 Market Share Analysis, By Application
5.3 End users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Clinics
5.3.4 Academic research institutes
5.3.5 Pharmaceutical and Biotech vendors
5.3.6 Laboratories
5.3.7 Others
5.3.8 Y-o-Y Growth Analysis, By End users
5.3.9 Market Attractiveness Analysis, By End users
5.3.10 Market Share Analysis, By End users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Application
6.1.3.4 By End users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Application
6.1.4.4 By End users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Application
6.1.5.4 By End users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Roche Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 DiaSorin S.p.A
8.3 Beckman Coulter
8.4 Siemens Healthcare
8.5 Ortho Clinical Diagnostics
8.6 bioMerieux
8.7 Thermo Fisher Scientific
8.8 Abbott Laboratories
8.9 Akers Biosciences
8.10 Becton Dickinson and Company
8.11 Devon Medical Products
8.12 EDP Biotech Corporation
8.13 Hologic
8.14 Intrinsic LifeSciences
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
